SM

Samir Mitragotri

Founder of inTUMO Therapeutics

Cambridge, Massachusetts

Overview 

Samir Mitragotri is a Professor at Harvard University, holding prestigious roles such as Hiller Professor of Bioengineering and Hansjorg Wyss Professor of Biologically Inspired Engineering at the Wyss Institute. With a Ph.D. from MIT and a B.S. from the University of Mumbai, he has founded multiple successful companies and made significant contributions to drug delivery and biotechnology research throughout his career. Mitragotri's career highlights include founding multiple successful companies such as inTUMO Therapeutics, Fount Bio, and CAGE Bio Inc., along with making notable contributions to the fields of drug delivery and biotechnology research as a Professor at Harvard University and core faculty member at the Wyss Institute.

Work Experience 

  • Professor

    2017 - Current

    Hiller Professor of Bioengineering and Hansjorg Wyss Professor of Biologically Inspired Engineering

  • Founder

    2018

Fount Bio is a life science company that applies proprietary advances in glycopolymer research for skin health.

Raised $8,157,203.00 from Morningside Venture Investments.

  • Founder

    2018

Cage Bio develops novel products for dermatology, inflammation, and immunology.

Raised $12,705,935.00 from Propel(X).

  • Founding Partner

    2016

  • Founder

    2019 - 2023

I2o Therapeutics is a biotech company that develops safe and effective oral formulations of therapies.

Raised $90,439,921.00 from Viva BioInnovator.

  • Mellichamp Professor of Chemical Engineering

    2000 - 2017

  • Founder

    2008 - 2012

YourBio Health optimizes the interface of diagnostic medicine and healthcare consumer by simplifying blood sampling and testing.

Raised $98,163,337.00 from Newpath Management and Flagship Pioneering.

  • Founder

    2004 - 2007

    Acquired by Corium International

Articles About Samir

Relevant Websites